Discover the latest articles and news in related subjects. Costabile and associates were among the first to examine the effects of transurethral alprostadil in men with ED after radical prostatectomy ...
MOUNTAIN VIEW, Calif., Oct. 4 VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma company - for MUSE®, ...
Meda in deal with two American Companies Meda has signed a long-term license agreement with Vivus for the exclusive marketing rights of MUSE® (alprostadil) in Europe. VIVUS markets MUSE in the US and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results